Current therapy for chronic hepatitis C: The role of direct-acting antivirals

One of the most exciting developments in antiviral research has been the discovery of the direct-acting antivirals (DAAs) that effectively cure chronic hepatitis C virus (HCV) infections. Based on more than 100 clinical trials and real-world studies, we provide a comprehensive overview of FDA-approv...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guangdi, De Clercq, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172984/
https://www.ncbi.nlm.nih.gov/pubmed/28238877
http://dx.doi.org/10.1016/j.antiviral.2017.02.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172984/
https://www.ncbi.nlm.nih.gov/pubmed/28238877
http://dx.doi.org/10.1016/j.antiviral.2017.02.014

Ejemplares similares